Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades (Q37645218)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1991

Language	Label	Description	Also known as
English	Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades	scientific article published on January 1991

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

Studies of central nervous system disorders with single photon emission computed tomography and positron emission tomography: evolution over the past 2 decades (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

computed tomography

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

0 references

author name string

Alavi A

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Hirsch LJ

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Seminars in Nuclear Medicine

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

58-81

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

The Mark IV system for radionuclide computed tomography of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Computerized transverse axial scanning (tomography). 1. Description of system

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Computerized transverse axial scanning (tomography). 2. Clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Local cerebral blood volume in head-injured patients. Determination by emission computed tomography of 99mTc-labeled red cells

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

A Positron-Emission Transaxial Tomograph for Nuclear Imaging (PETT)

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Clinical brain imaging with isopropyl-iodoamphetamine and SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Functional imaging of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Imaging dopamine receptors in the human brain by positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Two dopamine receptors: biochemistry, physiology and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Nomenclature of central and peripheral dopaminergic sites and receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Sight and insight: brain dopamine receptor occupancy by neuroleptics visualised in living schizophrenic patients by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography studies of normal aging: a replication of PET III and 18-FDG using PET VI and 11-CDG

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Sensitivity of Cerebral Glucose Metabolism to Age, Gender, Brain Volume, Brain Atrophy, and Cerebrovascular Risk Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography imaging of regional cerebral glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography and histopathology in Pick's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The diagnosis of dementia with single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography in patients with glioma. A predictor of prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Tomographic studies of rCBF with 99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Computerized tomography, magnetic resonance imaging, and positron emission tomography in the study of brain trauma. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Changes in cerebral perfusion after acute head injury: comparison of CT with Tc-99m HM-PAO SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The Etiology of Acute Brain Swelling Following Experimental Head Injury

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

CEREBRAL VASOMOTOR PARALYSIS PRODUCED BY INTRACRANIAL HYPERTENSION.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional Cerebral Blood Flow Estimated by 133 Xenon Inhalation

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional Cerebral Blood Volume During Acute Transient Rises of the Intracranial Pressure (Plateau Waves)

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Compression of cerebral vessels by intracranial hypertension. II. Morphological evidence for collapse of vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Computed Tomography of Pediatric Head Trauma: Acute General Cerebral Swelling

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral circulation after head injury. 1. Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Metabolic and clinical correlates of acute ischemic infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron Imaging in Ischemic Stroke Disease Using Compounds Labeled With Oxygen 15

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron tomography in ischemic cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron CT imaging of an impending stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Remote metabolic effects of cerebrovascular lesions: magnetic resonance and positron tomography imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Assessment of regional cerebral blood flow (rCBF) in stroke using SPECT and N-isopropyl-(I-123)-p-iodoamphetamine (IMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

SPECT with N-isopropyl-p iodoamphetamine in occlusive cerebrovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

rCBF in patients with carotid occlusion. Resting and hypercapnic flow related to collateral pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The rCBF response to Diamox in normal subjects and cerebrovascular disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Crossed cerebellar diaschisis in ischemic stroke: a study of regional cerebral blood flow by 133Xe inhalation and single photon emission computerized tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Crossed cerebellar diaschisis in patients with cerebral ischemia assessed by SPECT and 123I-HIPDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral hemispheric and contralateral cerebellar hypoperfusion during a transient ischemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Remote effects of subcortical cerebrovascular lesions: a SPECT cerebral perfusion study

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral infarctions studied by [123I]iodoamphetamine. Clinical aspects of the findings on single photon emission computed tomography and transmission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Technetium 99m HMPAO scanning in patients with subarachnoid haemorrhage: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The role of positron emission tomography in the evaluation of seizure disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Local cerebral metabolism during partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Localization of epileptic foci with postictal single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Initial experience with SPECT imaging of the brain using I-123 p-iodoamphetamine in focal epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

SPECT measurements with 99mTc-HM-PAO in focal epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

HIPDM-SPECT in patients with medically intractable complex partial seizures. Ictal study

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cognitive function and regional cerebral blood flow in partial seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Single photon emission computerized tomography during and between seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Single photon emission computed tomography (SPECT) brain imaging using N,N,N'-trimethyl-N'-(2 hydroxy-3-methyl-5-123I-iodobenzyl)-1,3-propanediamine 2 HCl (HIPDM): intractable complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

HIPDM single photon emission computed tomography brain imaging in partial onset secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

99mTc-labelled hexamethylpropyleneamine oxime photon emission scans in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

PET and movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography in the early diagnosis of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Studies in persons at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Normal caudate glucose metabolism in persons at risk for Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Monoamine re-uptake sites in the human brain evaluated in vivo by means of 11C-nomifensine and positron emission tomography: the effects of age and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Evaluation of brain imaging techniques in mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Hypofrontality in schizophrenia: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional cerebral blood flow in schizophrenia: repeated studies during a psychotic episode

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single photon emission computed tomography and Tc99m-hexamethylpropyleneamineoxim

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

From syndrome to illness: delineating the pathophysiology of schizophrenia with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Reversibility of hemodynamic hypofrontality in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cortical "stress tests" in schizophrenia: regional cerebral blood flow studies

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: relationship to symptom specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional Brain Function in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

The potential value of serial cerebral SPECT scanning in the evaluation of psychiatric illness

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Neurophysiological aspects of auditory hallucinations. 99mTc-(HMPAO)-SPECT investigations in patients with auditory hallucinations and normal controls--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Left globus pallidus abnormality in never-medicated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

No D2 receptor increase in PET study of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional cerebral blood flow in depression and mania

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Regional cerebral blood flow in depression: associations with psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Positron emission tomographic study of affective disorders: problems and strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

An assessment of the role of 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathological classification of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980079-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0001-2998(05)80079-0

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37645218&oldid=1718111793"